Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Current Pharmaceutical Biotechnology|February 18, 2022
Transcription Factors and Regulators Pathway-focused Genes Expression Analysis in Patients with Different Forms of Thyroid PathologyIryna Kamyshna, Aleksandr Kamyshnyi
Frontiers in Molecular Biosciences|October 26, 2023
Unveiling the potential pleiotropic effects of metformin in treating COVID-19: a comprehensive reviewPavlo Petakh, Iryna Kamyshna, Aleksandr Kamyshnyi
Molecular Metabolism|September 11, 2023
Effects of metformin on the gut microbiota: A systematic reviewPavlo Petakh, Iryna Kamyshna, Aleksandr Kamyshnyi
Inflammopharmacology|September 29, 2023
Gene expression of protein kinase AMP-activated catalytic subunit alpha 1 (PRKAA1), solute carrier family 2 member 1 (SLC2A1) and mechanistic target of rapamycin (MTOR) in metformin-treated type 2 diabetes patients with COVID-19: impact on inflammation markersPavlo Petakh, Iryna Kamyshna, Aleksandr Kamyshnyi
Viruses|February 24, 2024
Metformin Alters mRNA Expression of <i>FOXP3</i>, <i>RORC</i>, and <i>TBX21</i> and Modulates Gut Microbiota in COVID-19 Patients with Type 2 DiabetesPavlo Petakh, Iryna Kamyshna, Valentyn Oksenych, et al.
Viruses|January 23, 2024
Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD: Insights from a Single-Center Prospective Cohort StudyMykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, et al.
Frontiers in Nutrition|June 30, 2025
Effect of vitamin D supplementation on COVID-19 outcomes: an umbrella review of systematic reviewsPavlo Petakh, Iryna Kamyshna, Iryna Halabitska, et al.
Frontiers in Medicine|February 5, 2025
Recent advances in the management of knee osteoarthritis: a narrative reviewViktor Shtroblia, Pavlo Petakh, Iryna Kamyshna, et al.
Pharmaceuticals (Basel, Switzerland)|June 28, 2023
Metformin Therapy Changes Gut Microbiota Alpha-Diversity in COVID-19 Patients with Type 2 Diabetes: The Role of SARS-CoV-2 Variants and Antibiotic TreatmentPavlo Petakh, Iryna Kamyshna, Valentyn Oksenych, et al.
Viruses|May 27, 2023
The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current EvidenceMykhailo Buchynskyi, Iryna Kamyshna, Valentyn Oksenych, et al.
Pageof 4